Our data support the second proposal, as in clonogenic assays MGMT inhibitor O6BG alone killed more efficiently GBM cells with low MGMT expression, and O6BG had more than additive effects with TMZ (Figure 2 and Table S2). This evidence concerns the gene MGMT and glioblastoma.